Building the financial case for treating childhood cancer in resource‐limited settings

For children diagnosed with cancer, the cost of delivering treatment services has, until recently, been largely assumed as too expensive and not cost‐effective, with little to no evidence from low‐ and middle‐income countries to support these assumptions. In this issue of Cancer , Denburg et al have demonstrated that the treatment costs associated with pediatric Burkitt lymphoma care in Uganda are surprisingly modest and very...